Preclinical data for VCN-12, the next candidate from Theriva’s VCN-X discovery program, highlight a novel mechanism of action ...
Researchers at Texas A&M’s Health Science Center have developed a photo-inducible binary interaction tool, or PhoBIT, system ...
Trogenix has raised £70m ($95m) in Series A financing to help bring its “Trojan horse” cancer treatment into clinical trials, ...
Japanese scientists successfully eliminated cancer tumors using live bacteria, a new therapy that acts independently of the ...
In a preclinical study, UC Davis Comprehensive Cancer Center scientists have developed a highly targeted gene therapy that ...
Telomir Pharmaceuticals Inc. (NASDAQ:TELO) shares surged 27.5% in premarket trading on Tuesday after the preclinical-stage biotechnology firm announced new data showing that its experimental therapy ...
Findings show that Telomir-1 restores the body’s natural tumor suppressor defenses by reversing abnormal DNA methylation of ...
News-Medical.Net on MSN
Engineered Salmonella therapy delivers immune payloads to combat cancer
A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled "ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL ...
News-Medical.Net on MSN
Gene expression test identifies prostate cancer patients who benefit from hormone therapy
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
SurvivorNet on MSN
A True Game-Changer in Prostate Cancer: A Simple Genomic Test Can Tell Us Who Needs Hormone Therapy And Who Doesn’t
How do we know which patients truly need this difficult treatment and which patients can safely skip it? The answer has arrived, delivered at the American Society for Radiation Oncology (ASTRO) 2025 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback